J. Safra Asset Management’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
RCM
ACA
JT
J. Safra Asset Management's ASND Position: Q2 2026 in Review
J. Safra Asset Management reduced its Ascendis Pharma A/S (ASND) stake by 17% in Q2 2026, selling an estimated $5.84K and leaving 121 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #288.
J. Safra Asset Management first reported a position in ASND in Q2 2024 and has held it in 9 quarters since. The position peaked at $33.4K in Q1 2026. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- J. Safra Asset Management held 121 shares of Ascendis Pharma A/S worth $32.3K as of Q2 2026.
- J. Safra Asset Management sold 25 Ascendis Pharma A/S shares in Q2 2026, an estimated $5.84K.
- Ascendis Pharma A/S made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #288 holding.
- J. Safra Asset Management first reported a position in Ascendis Pharma A/S in Q2 2024 and has held it in 9 quarters since.
- J. Safra Asset Management's Ascendis Pharma A/S position peaked at $33.4K in Q1 2026.
- 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.